ETC-1002

Esperion Falls on Regulatory Setback for Cholesterol-Lowering Pill
TheStreet.com
Tue, 06/28/16 - 05:39 pm
Esperion Therapeutics
LDL-C
ETC-1002
Esperion surges after FDA offers a shot at quick approval for LDL-lowering drug
Fierce Biotech
Mon, 08/17/15 - 07:14 pm
FDA
Esperion Therapeutics
LDL cholesterol
ETC-1002
Why Regeneron’s Approval is Bad News For Esperion Therapeutics
Barron's
Mon, 07/27/15 - 01:55 pm
Regeneron
Esperion Therapeutics
Sanofi
Praluent
Amgen
Repatha
ETC-1002
The FDA Breathes New Life Into Esperion's ETC-1002
Motley Fool
Thu, 07/9/15 - 10:30 am
FDA
Esperion Therapeutics
ETC-1002
5 Biotech Stocks On Deck With The FDA
Yahoo/Benzinga
Tue, 06/30/15 - 06:13 pm
FDA
Alnylam
Patisiran
Esperion Therapeutics
ETC-1002
Intercept Pharmaceuticals
obeticholic acid
Sarepta Therapeutics
eteplirsen
Tekmira
TKM-PLK1
1 Tiny Biotech's Blockbuster Opportunity in Heart Disease
Motley Fool
Sun, 03/22/15 - 10:49 am
ETC-1002
heart disease
Esperion Therapeutics
Esperion cholesterol drug succeeds mid-stage study
Yahoo/Reuters
Tue, 03/17/15 - 07:14 pm
Esperion
ETC-1002
Esperion shares rally on cholesterol drug study results
Marketwatch
Wed, 10/1/14 - 06:41 pm
Esperion Therapeutics
ETC-1002
Merck
Zetia
Small Esperion Vs Pharma Giants In The Cholesterol Race
Seeking Alpha
Mon, 11/11/13 - 10:35 am
Esperion Therapeutics
ETC-1002
Sanofi
Regeneron
Amgen
Pfizer
Roche
Esperion's drug lowers blood fat in mid-stage study
Reuters
Tue, 09/3/13 - 10:40 am
Esperion Therapeutics
ETC-1002
In Moribund Cholesterol Field, A New Drug Emerges
Forbes
Thu, 04/25/13 - 09:27 am
ETC-1002
Pfizer
Esperion
Merck
Amgen
Sanofi
AstraZeneca